The overall goal of this resource is to provide expertise in vivo image acquisition and analysis and to develop, adapt and optimize novel imaging systems and techniques for small animals. Small animal models, particularly mice (inbred, immunodeficient, genetically engineered), are increasingly recognized as powerful tools in cancer research. While some of the small animal imaging resources are shared (muMRI, muPET), others are available within the CMR (nuclear imaging, MIRF imaging, optical imaging). This Resource in particular addresses the urgent need to image specific cellular, molecular and genetic information from tumors in vivo. A major strength of this Resource is the interdisciplinary research using complementary research using complementary image acquisition and common image analysis approach.
The specific aims i nclude 1) optimize existing 3d muMRI high resolution NMR anatomic imaging, 2) develop solid state high resolution, high efficiency scientigraphic imaging system and optimize it for imaging of viruses, phages, DNA and cells in mice, 3) build a multi-channel near infrared optical imaging system for mice analogous to the one developed and optimize and validate for different probes, 4) develop novel methods and protocols for fusion of anatomic and functional/molecular images and 5) assist in image acquisition, interpretation, quantitation, data management, resource scheduling, maintenance and animal preparation. The long-term goals of the resource are to further high resolution, high molecular contrast imaging technology in mice and to provide imaging services and expertise to all research and pilot projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA086355-03
Application #
6647287
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-08-15
Project End
2003-07-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$241,412
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Dubach, J Matthew; Kim, Eunha; Yang, Katherine et al. (2017) Quantitating drug-target engagement in single cells in vitro and in vivo. Nat Chem Biol 13:168-173
Vinegoni, Claudio; Fumene Feruglio, Paolo; Brand, Christian et al. (2017) Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging. Nat Protoc 12:1472-1497
Iaconelli, Jonathan; Lalonde, Jasmin; Watmuff, Bradley et al. (2017) Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells. ACS Chem Biol 12:2139-2148
Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H et al. (2017) In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 9:
Miller, Miles A; Weissleder, Ralph (2017) Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev 113:61-86
Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas et al. (2017) Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science 358:
Miller, Miles A; Askevold, Bjorn; Mikula, Hannes et al. (2017) Nano-palladium is a cellular catalyst for in vivo chemistry. Nat Commun 8:15906
Pucci, Ferdinando; Garris, Christopher; Lai, Charles P et al. (2016) SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 352:242-6
Roy, Jeremy; Kim, Bongki; Hill, Eric et al. (2016) Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun 7:10666
Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen et al. (2016) Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity 44:343-54

Showing the most recent 10 out of 316 publications